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What Is It about?
Digital technologies and the digital environment offer new opportunities for identifying needs and 
delivering healthcare from prevention and health promotion to curative interventions and self-
management. This paper sets out the framework for the opportunities both to respond to health emer-
gencies and to deliver the sort of care that can bring personalised healthcare benefits every day. These 
opportunities, so near yet so far, will remain out of reach until there is real data harmonisation and 
interoperability, optimisation of data collection, sharing and analytics, and wide acceptance and 
adoption of innovative digital tools in a COVID-19 and post-COVID-19 world.
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2Biomed Hub 2020;5:511232
Horgan et al.: Digitalisation and COVID-19
www.karger.com/bmh
© 2020 The Author(s). Published by S. Karger AG, BaselDOI: 10.1159/000511232
Abstract
“A ship in the harbour is safe, but that is not what ships are built for,” observed that sage 19th 
century philosopher William Shedd. In other words, technology of high potential is of little 
value if the potential is not exploited. As the shape of 2020 is increasingly defined by the coro-
navirus pandemic, digitalisation is like a ship loaded with technology that has a huge capac-
ity for transforming mankind’s combat against infectious disease. But it is still moored safely 
in harbour. Instead of sailing bravely into battle, it remains at the dockside, cowering from the 
storm beyond the breakwaters. Engineers and fitters constantly fine-tune it, and its officers 
and deckhands perfect their operating procedures, but that promise is unfulfilled, restrained 
by the hesitancy and indecision of officialdom. Out there, the seas of the pandemic are tur-
bulent and uncharted, and it is impossible to know in advance everything of the other dangers 
that may lurk beyond those cloudy horizons. However, the more noble course is for orders to 
be given to complete the preparations, to cast off and set sail, and to join other vessels crewed 
by valiant healthcare workers and tireless researchers, already deeply engaged in a rescue 
mission for the whole of the human race. It is the destiny of digitalisation to navigate those 
oceans alongside other members of that task force, and the hour of destiny has arrived. This 
article focuses on the potential enablers and recommendation to maximise learnings during 
the era of COVID-19. © 2020 The Author(s)
Published by S. Karger AG, Basel
Flashes of Lightning Are Not Enough: Data Must Be Enlightening
Against the darkness of the COVID-19 storm, a flickering light gives glimpses of the power 
of data and digital tools to protect and improve health and wellbeing, and inspires hope of 
what is to come. Telemedicine has taken on a new significance in care, and recognition has 
been forced on governments and international agencies of the central role of data in tracking 
and tracing outbreaks of infection – generating unprecedented activity in the search for and 
development of suitable technology. But the light is intermittent rather than constant, and the 
recurrent blackouts expose how much still needs to be done to achieve systematic and reliable 
healthcare digitalisation. Opportunities are being missed, both to respond to health emer-
gencies, and to deliver the sort of care that can bring personalised healthcare benefits every 
day. Those opportunities, so near yet so far, will remain out of reach until there is real data 
harmonisation and interoperability, optimisation of data collection, sharing and analytics, 
and wide acceptance and adoption of innovative digital tools.
Show Me Your Data – and Quickly, Too!
Data is the essential fuel for digitalisation, and a strong data ecosystem is the infra-
structure required to deliver that fuel in a successful response to COVID-19. But at the level 
of this most basic need, progress is hampered by severe limitations in the ability of many 
jurisdictions to collect, harmonise, and share high-quality data. These limitations have been 
more cruelly exposed than ever by the pandemic. The negative consequences for the effec-
tiveness and efficiency of health systems has become all too apparent, as – for instance – in 
the fragmentation of the US healthcare system’s data pipelines and data reporting, the 
disconnect between clinical and public health systems, between states, and in the decen-
tralised and haphazard data collection with inconsistent definitions and ontologies. Some 
countries have proved more effective in building robust data pipelines and interoperability 
between clinical and public health as well as with partner organisations in immigration, 
education, and business sectors, notably in Taiwan [1].
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The authorities responsible for health systems are being driven to a new recognition of 
just how critical the availability and sharing of comprehensive health data is to addressing 
major public health challenges. Acceptance of the principle of FAIRification – of ensuring data 
meets clear and agreed standards – would expand the concept of quality across the entire 
cross-border data workflow. The pandemic has shattered widespread assumptions that the 
type and scope of health information exchange is only a marginal consideration in healthcare, 
and is highlighting the importance of health information technology and data interopera-
bility. The experience has demonstrated the importance of factors that were known but 
barely accepted: data have value only if they are used – collection itself serves no purpose 
without access and use, and aggregations of small collections of data do not necessarily 
represent value. This is why healthcare institutions and private companies need to adhere to 
common data standards and give greater importance to the value of federation. It has revealed 
the risks, inefficiencies, and loss of information by having siloed systems between clinical and 
public health bodies. 
Influential voices from around the world – in academia, governments, and international 
organisations – are chorusing the need for change. Patients’ medical data is not enough to 
efficiently manage a pandemic like this: collection should also encompass data from a local 
epidemiologic context [2–4] and individuals’ online and offline activity, and the health infor-
mation exchange should take place “at least nationally, if not internationally,” according to a 
research fellow at Brookings Institution [5]. 
The merits of sharing information globally have been repeatedly underlined. “It is a virus 
that has shown that information sharing, transparency and collective action are necessary,” 
says an expert in international affairs at the University of Waterloo [6]. Even historians point 
to “the big advantage” over viruses that humans can deploy by international data sharing: a 
coronavirus strain in China and another strain in the USA cannot swap tips about how to 
infect humans, “but China can teach the US many valuable lessons about coronavirus and how 
to deal with it.” However, there are preconditions, too: “For this to happen, we need a spirit 
of global co-operation and trust” [7].
Researchers at Oxford also identify gaps that must be filled on knowledge about 
COVID-19’s transmissibility, the risk of geographic spread, routes of transmission, and risk 
factors for infection, as well as to provide the baseline for epidemiological modelling. “The 
epidemic is unfolding rapidly and reports are outdated quickly, so it will be necessary to build 
computational infrastructure that can handle the large expected increase in case reports,” 
they say: “Data sharing will be vital to evaluate and maintain accurate reporting of cases 
during this outbreak” [8].
More data, wider, deeper, harmonised and faster data are seen as prerequisites for 
success: “Rapid data sharing is the basis for public health action,” states a WHO article, high-
lighting the dependency of decision-makers on information from peer-reviewed journals and 
online datasets. “The release of full viral genome sequences through a public access platform 
and the polymerase chain reaction assay protocols that were developed as a result made it 
possible to accurately diagnose infections early in the current emergency,” it recalls [9]. “It is 
necessary for all countries including China, to promptly share epidemiological information 
on this new disease,” adds the Korean Task Force [10] (Fig. 1).
The pandemic has shown the need for creating a cross-border domain for co-operation 
that must support stakeholders and, in particular, policy makers with responsibilities in the 
areas of public health and provision of healthcare services with real-time evidence to help 
them to recognise when to shift the strategies that they are using. Only cross-border, multi-
sector, and multi-disciplinary research collaboration based on existing networks and part-
nerships will create an efficient process of data integration. What is needed is greater political 
will to align and share data. Greater awareness of the mutual benefit would be a powerful 
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incentive to share, and to build collection pipelines with interoperability in mind. In this 
respect, COVID-19 is a rare prompt for new collaboration across industry, academia, and 
government for the public good – which could permit real insights to be gained from digital 
data.
Navigating by More than the Stars
Learning from Experience
It is now time to learn, and to optimise systems to facilitate the provision of effective 
patient care, overcoming the traditional difficulties in the translation of biomedical research 
into clinical practice. A new and effective path is needed to address the organisational, oper-
ational, and legal barriers, responding to the urgency that a second wave of COVID-19 or new 
pandemic will impose.
The greatest successes have been secured in combating COVID-19 by jurisdictions that 
have leveraged previous efforts in building the principal components of a health data 
ecosystem, as Taiwan, Germany, and South Korea – and even nations with lower GDP and 
social infrastructure, such as Uruguay and Vietnam – have demonstrated [11–13].
Taiwan rapidly mobilised and instituted specific approaches for case identification, 
containment, and resource allocation. It integrated its national health insurance, immigration, 
and customs databases to exploit big data for analytics. Using data on travel history and 
clinical symptoms, it generated real-time alerts during clinical visits to aid case identification. 
It also combined QR code scanning and online reporting of travel history and health symptoms 
to classify travellers’ infectious risks based on their recent travel history [1]. The process was 
facilitated by the country’s single-payer health program which contains digital medical 
records for every citizen [14], with the socio-cultural context another possible factor. To 
precisely track coronavirus exposure, South Korea used additional digital records – medical 
and pharmacy visits, history of credit card transactions, and CCTV videos – in determining 
where potentially exposed people had been and followed up infected people and also their 
acquaintances [15]. 
Germany’s implementation of digital solutions for patients and doctors now bring 
benefits in support from apps and telemedicine services for medical professionals and care-
givers and provide patients with information about COVID-19, according to Prof. Jörg Debatin, 
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Fig. 1. A data ecosystem. 
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head of the Health Innovation Hub think tank, set up by the Federal Ministry of Health. The 
hub has released a list of trusted telemedicine services (including costs, reimbursement 
policies, functionality, and pricing) that can be easily integrated into medical practice without 
technical expertise or hardware investments. Thousands of doctors have started to take 
advantage of these, says Debatin. Secure digital platforms that enable doctor-patient interac-
tions are also particularly helpful at this time when citizens are concerned about their health 
and cut off from health services [16].
Charting New Waters
Mind the Gap!
COVID-19 has exposed the negative impacts of the disconnect between clinical and 
public health and weak data ecosystems on health system efficiency and public health 
responsiveness. The delivery of accurate and comprehensive data with the necessary rapidity 
is a widespread challenge – often because of inadequate processes, aggravated by differing 
models, methodologies, and technologies across countries and regions that impede compi-
lation, aggregation, and comparison. A lack of centralisation characterised by bespoke 
systems precludes common expectations or requirements, a lack of adequate agreed data 
models militates against data quality, granularity, and completeness, and insufficient 
investment in technology and electronic pipelines impedes reporting and collection. The 
problems are political, methodological, scientific, technical, and economic. Even the WHO 
and ECDC are not immune.
Researchers at Duke University point to the lack of a cohesive data model for patients in 
most electronic health records, which prevents clinicians from tracing back to a patient’s 
signs, symptoms, and diagnostic tests, and there has been resistance in some quarters to 
interoperability across proprietary systems. Existing capabilities are inadequate for scaling 
up the tracking of patients in an electronic health record system from the current dozens to 
hundreds or thousands, they say [17].
Delays in getting results for the thousands of coronavirus tests commissioned daily could 
hinder efforts to track the number of coronavirus tests performed nationwide and the spread 
of the disease, warned HHS Secretary Alex Azar, in the face of criticisms of the medical system’s 
antiquated tracking systems, which is expected to reduce some healthcare providers to faxes 
or phone calls to report data. Brian Dixon of the Regenstrief Institute health research organ-
isation complains that “there is no infrastructure in the USA for tracking the number of tests 
ordered for just about anything,” and even if communications are sorted out between labs 
and doctors, gaps will remain with public health agencies [18], which have completely 
different pipelines, governance and reporting rules.
The Swiss government has struggled to maintain an accurate record of novel COVID-19 
infections, partly as a result of an outdated methodology and suboptimal data infrastructure, 
but also because of the decentralised approach. The absence of electronic patient records 
obliges cantons to flag new cases on forms faxed to the central government, and federal 
authorities wait for confirmation by the reference lab in Geneva before manually aggregating 
data [19].
 Our World in Data, an online publication based at the University of Oxford, has stopped 
relying on WHO data for its models, citing errors and inconsistencies, and the lack of good 
data is frustrating for economists, statisticians, scientists, and public policy professionals. 
Prof. John Ioannidis of Stanford University fears the pandemic could end up being “a once-in-
a-century evidence fiasco” [20].
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Racing to Remedy the Failings
Many jurisdictions are bringing in changes in a desperate bid to fill the gaps that have 
been exposed in healthcare digitalisation – changes that are reimagining relationships with 
and approaches to managing health data. Governments are investing in enhanced integration 
of healthcare data and speeding up access, so as to improve clinical and public health decision 
making and healthcare system efficiency.
In the UK, NHS Digital has been empowered to deliver new services and to use data more 
efficiently, through collecting and analysing data to help doctors, nurses and other health 
professionals to understand the illness better, to identify patients or those at risk, to under-
stand NHS responses to the threat, and to provide advice and information for NHS and social 
care staff [21]. The NHS is also working with Cerner on an electronic health records platform 
for the temporary Nightingale hospital in London, and on expanding EHR functionality in 
other UK hospitals to grant clinicians access to real-time information about COVID-19 patients 
[22]. Integration between public health and clinical practice will also have to be implemented 
for the full effect.
The Ontario government is developing a secure health data platform that will provide 
researchers with access to de-identified, integrated data on publicly funded administrative 
health services records, including physician and medical drug claims, hospital visit and 
discharge summaries, and claims for home care and long-term care. It will also contain clinical 
data from special registry collections, extracted from public health, hospital, laboratory, and 
diagnostic imaging information systems [23]. Moves towards harmonisation in the hospital 
systems in the neighbouring province of Quebec also have the potential to increase health 
digitalisation beyond COVID-19 [24].
The US CDC is receiving USD 500 million for modernising its analytics infrastructure for 
public health data surveillance, and for a new system to gather data on how the virus is 
spreading [25]. Ireland’s Health Service Executive has commissioned a system providing 
remote monitoring of otherwise healthy patients with mild to moderate symptoms who are 
in self-isolation [26]. Singapore launched a contact-tracing app [27]. The question remains 
open, however, as to how far it might prove possible to federate the data from these initia-
tives.
Widening Access to Digital Data
The challenges are not merely technical. There has also been resistance to change among 
established systems. But the pressing needs of the moment are starting to erode some of 
those constraints and to promote a pragmatic flexibility – in terms of accepting new method-
ologies and even modifying payment systems to permit their deployment.
Jurisdictions are authorising new access to digital health tools such as remote patient 
monitoring and virtual clinician-patient engagement. In the USA, Medicare telehealth coverage 
has been widened to reduce patients’ need to travel to a healthcare facility, with new payment 
systems for clinicians for telehealth services [28]. The FDA has also enabled greater use of 
remote patient monitoring technologies to cut back on hospital visits, and is easing the rules 
on clinical decision support software in order to promote the development of products that 
can provide advice on diagnosis and treatment [29, 30]. Also, the Department of Health and 
Human Services has broadened the acceptable technologies for telehealth to include Apple 
FaceTime, Facebook Messenger video chat, Google Hangouts video, and Skype [31].
In Canada, British Columbia has lifted a requirement that personal data must be stored 
in the country, so as to allow the use of digital communication tools such as WhatsApp or Slack 
[32]. Alberta is now compensating doctors for providing virtual care during the pandemic 
[33]. France too has authorised unconditional teleconsultation procedures for people poten-
tially infected [34].
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From Astrolabes to GPS
Digital Innovation to the Rescue
The digital tools developed by innovators in response to the pandemic – in some cases in 
partnership with governments – have reinforced the importance and possibility of digital 
health innovation more broadly. New approaches are helping ease the strain on overstretched 
healthcare facilities, or enabling patients to conduct an initial self-diagnosis, or generating 
macro data on the spread of disease by aggregating individual patient or physician data.
Innovation is leading to rapidly evolving possibilities for dealing with COVID-19 patients. 
Automated digital tools for triaging patients and healthcare decision making such as Blue 
Shield of California’s COVID-19 Screener and Emergency Response Assistant help hospitals 
ease the flow of patients seeking advice through initial triage before directing patients to the 
appropriate sites of care [35].
The potential application of AI to the management of COVID-19 faces several barriers. AI 
needs large amounts of correctly structured information to be trained and, while information 
is becoming ever easier to obtain, the infrastructure to mine, integrate, and share the data in 
compliance with all relevant ethical, legal, and regulatory requirements remains lacking. 
Epidemiological data are geographically dispersed and siloed in different medical institu-
tions, hindering the building of representative reference population datasets, and the devel-
opment of unbiased AI-powered tools.
The speed of health system evolution in these new circumstances can also present chal-
lenges for many established practices. Because outpatient services may find it difficult to keep 
up with novel demands, automated logic flows (bots) are being developed that can refer 
moderate-to-high-risk patients to nurse triage lines and schedule video visits with estab-
lished or on-demand providers [36]. Hospitals in Baltimore are using a digital telehealth tool 
that monitors healthcare workers for 14 days after potential exposure to COVID-19, and 
triages cases [37]. In Chicago, COVID-19 clinical pathways are embedded into electronic 
health records to maximise efficient workflows [38]. Content from the CDC and the Mayo 
Clinic is incorporated in devices for front-line health responders to improve screening and 
support for patients [39].
An AI chatbot helps patients self-assess for the risk of COVID-19 and gives guidance to 
nearby lab centres, as well as feeding the data into different healthcare ecosystems [40]. In 
Korea, an automated risk assessment application checks symptoms and epidemiological 
factors for both health workers and patients [41].
London hospitals are using an app to help track the spread of COVID-19 and identify indi-
viduals most at risk [42], and an AI-powered COVID-19 self-evaluation technology combines 
information inputted by users with professional medical guidance to help determine a 
potential infection [43]. Real-time COVID-19 dashboards inform healthcare decisions over 
patient prioritisation and testing availability and production, including data on the number 
of tests ordered by clinicians and the number of people with risk factors [44].
Using Your Intelligence
The wealth of new data that is being generated presents a problem in itself, since its sheer 
scale exceeds the capacity of established systems for analysing and exploiting it. Here, the 
rapidly emerging techniques of AI and machine learning are coming into their own. AI has 
transformed the scope of many of these data-collection innovations, and is using it for 
powering tools that convert raw data into valuable inputs to urgently needed developments 
in outbreak mapping, real-time surveillance, and drug discovery.
A Canadian firm specialised in automated infectious disease surveillance uses machine 
learning and natural language processing techniques to sift through news reports in 65 
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languages, and through forum and blog posts, airline ticketing data, and animal disease 
networks to pick up indications and news of unusual, unfolding events and possible disease 
outbreaks. The firm employs trained epidemiologists to further analyse outbreak results 
obtained by automated means before releasing them to its clients [45, 46].
Alphabet’s Google, Facebook, and Apple have separately announced launches of COVID-19 
mapping tools, which have been built on location tracking data from users’ devices. Google’s 
Community Mobility Reports web tool demonstrated that in New York time spent at work-
places was down 46%, and its coverage is being expanded to hundreds of countries and 
regions. Facebook has launched a “co-location map” evaluating the probability that different 
Facebook users will come into contact with each other in person, a “Movement Range Map” 
revealing if people are staying near their homes on a county-by-county level, and a “Social 
Connectedness Map,” using “friends” across geographic lines to understanding where the 
disease could spread [47, 48]. Alphabet’s Google Cloud is collaborating with a Tennessee-
based health system on a COVID-19 National Response Portal that promotes safe sharing 
across the USA of de-identified, aggregated patient-level data (such as ICU bed and equipment 
supply, diagnostic results, discharge numbers) from hospitals into a single platform to show 
a complete and real-time view of the pandemic [49]. Other AI applications report on the effec-
tiveness against COVID-19 of a drug approved for rheumatoid arthritis, or assist in the design 
of new molecules that could halt viral replication [46].
Recruiting Leading-Edge Technology to the Combat
The battle against COVID-19 has provided new impetus for genome-sequencing tools 
that are increasingly finding their place in the front line. One free-of-charge web-based bioin-
formatics pipeline, the Genome Detective Coronavirus Typing Tool, can identify and classify 
coronavirus genomes at 2,000 sequences per submission, with analysis of a new whole-
genome sequence taking just a minute. It also identifies changes to nucleotides, coding 
regions, and proteins using a novel dynamic aligner to allow tracking of new viral mutations, 
as an aid to developing diagnostics, drugs, and vaccines [50].
With the advent of rapid bedside-to-bench investigation, new tools such as next-gener-
ation sequencing, and open access information, information on the clinical features of COVID-
19-infected patients, and the host immune responses are accumulating [51]. Also, a consumer 
genomics partner of GSK has launched a longitudinal study to investigate genetic influencers 
of severity in COVID-19 among hundreds of thousands of infected and non-infected indi-
viduals [52].
Digital Tools Providing Virtual Care
The virulence and transmissibility of the virus have conferred new value on safer and 
easier contact between doctors and patients. Technologies to allow this are becoming the new 
normal in the face of the pandemic, reducing the number of visits to general practitioners and 
hospitals and reducing risk, with many using an initial risk assessment questionnaire, and 
increasingly linked to anonymised population health data so as to display trends and varia-
tions.
A free web-based platform to connect healthcare professionals with patients via video 
consultations during the COVID-19 pandemic is able to facilitate appointments within 
minutes, and allows safe GP consultations for patients who are self-isolating or with chronic 
illnesses. Clinicians vulnerable to infection can also offer medical support without risking 
their own health [53]. Philips has also launched a telehealth solution for remote screening 
and monitoring of COVID-19 patients [54]. Furthermore, healthcare organisations are 
promoting personal health and wellness, particularly during increasing levels of stress and 
anxiety, through providing access to digital mental health apps [55].
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Time to Check the Spread
Smart watches and other wearables are being used to collect data and for remote moni-
toring solutions. Wearables are gaining a new relevance both to assist researchers to under-
stand the pandemic, and also to help people understand their health and react to signals. 
There are tens of millions of smartwatches being worn that could help in health protection 
against infectious diseases, in data provision, and in contact tracing. But the key is developing 
effective apps that can link wearables to data collection under an appropriate ethical gover-
nance – and in due course, perhaps for uses such as identifying individuals who have developed 
immunity.
A Scripps Research Translational Institute program would allow users with a Fitbit, 
Apple Watch, and other wearable devices to share data to be able to quickly detect the emer-
gence of fast-spreading viral illnesses. Since studies suggest that sleep and resting heart rate 
data correlated with the reports of influenza-like illness, the program can allow sharing data 
on heart rates, sleep, and activity levels to help detect viral illness outbreaks [56]. A Boston-
based start-up is using its wearable and artificial intelligence technology to remotely monitor 
coronavirus-infected and suspected patients and to apply personalised predictive analytics 
to provide more effective interventions. In Hong Kong, volunteers quarantined in their homes 
or hospitals will wear a device with built-in sensors on their upper arm 24 hours a day, trans-
mitting data on body temperatures, respiratory rates, blood oxygen levels, and heart rates to 
a digital platform. Real-time monitoring and analysis signals are fed through AI and machine 
learning techniques to flag key physiological changes that could indicate disease progression, 
and a linked smartphone app asks patients about symptoms [57]. Germany’s Robert Koch 
Institute and a start-up partner have launched a smartwatch app to monitor the spread of 
COVID-19 by reporting pulse, temperature, and sleep patterns. Results will be published in 
an online map detailing down to postcode level [58].
Forging New Teams to Crew the Voyage
Researchers Investigate Innovative Partnerships Too
This coronavirus outbreak has been unprecedented; so too is the way that the scientific 
community has responded to it. Researchers have openly and rapidly shared genomic and 
clinical data, allowing research results to be released almost instantaneously and helping 
understanding of the transmission dynamics and the development of rapid diagnostics, and 
informing the public health response [50].
The research community has responded to the COVID-19 crisis by accelerating collab-
orative efforts and data sharing, affirming integration and connectivity as key success factors 
in responding to health challenges and driving innovation.
Novel partnership models among researchers and innovative organisations from across 
sectors are demonstrating unprecedented transparency and sharing of data and resources. 
As pharmaceutical companies collaborate to speed the creation of therapies and vaccines to 
treat COVID-19, R&D heads from leading companies meet almost daily to produce an industry-
wide response unparalleled since World War II. Regulatory and manufacturing heads have 
also been meeting frequently to minimise duplication of effort, streamline work, and advance 
efficient testing of compounds and vaccines. “This is not a time to think about proprietary 
information or IP or margins. We need to break down the barriers and solve the problem,” 
said one participant involved in the consortium [59].
As examples, the Innovative Medicines Initiative project EHDEN (European Health Data 
Evidence Network) has sponsored a “study-a-thon” to encourage its massive research 
network to be used for COVID-19-related research queries, which are starting to generate fast 
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big data results. The recently formed Multiple Sclerosis Data Alliance has developed a 
COVID-19 research core dataset and started to collect this data from many collaborating 
multiple sclerosis registries and is diverting some of its funds to support the analysis of this 
data.
Pfizer, Johnson & Johnson, Merck, Sanofi, and Novartis have joined forces with another 
dozen pharmaceutical companies to share proprietary compound libraries in an effort to 
accelerate the development of therapeutics for COVID-19. The Bill and Melinda Gates Foun-
dation, working through the COVID-19 Therapeutics Accelerator it set up with the Wellcome 
Trust and Mastercard, is screening the libraries for potential candidates [60]. Microsoft, 
Amazon, Epic, and Mayo Clinic are among the founders of the COVID-19 Healthcare Coalition, 
which provides real-time learning to preserve healthcare delivery and protect US popula-
tions. Partners share assets, resources, and plans to support front-line responders to COVID- 
19 and a resource library will inform decisions on people at risk, healthy populations, social 
distancing efforts, and the healthcare delivery system [61]. The White House Office of Science 
and Technology Policy is developing the COVID-19 High Performance Computing Consortium 
with partners including IBM, Alphabet’s Google Cloud, Amazon Web Services, Microsoft, and 
many universities, to give researchers access to supercomputers to help speed the discovery 
of vaccines and drugs [62].
Under WHO’s co-ordination, 100 scientists, physicians, funders, and manufacturers are 
working on the development of vaccines against COVID-19 [63]. The National Research 
Council of Canada’s COVID-19 Pandemic Response Challenge Program has engaged 
government, academic, and private sector partners to address specific COVID-19 gaps and 
challenges in detection and diagnosis, therapeutics and vaccine development, and digital 
health [64]. Italian ministries and agencies have launched the “Innova per l’Italia” call to 
business and research to identify digital solutions and technologies for telemedicine, home 
care applications, and active monitoring of the risk of contagion [65].
Mapping population-wide adaptive immune responses to diseases at scale is being 
stepped up by Microsoft and Adaptive Biotechnologies, who are making the data available 
to researchers, public health officials, or organisations around the world via an open data 
access portal [66]. The COVID-19 Genomic UK Consortium, bringing together the NHS, the 
Wellcome Sanger Institute, and public health agencies and academic institutions, has 
obtained GBP 20 million for sequencing-based studies of COVID-19 transmission, and will 
deliver large-scale rapid sequencing of the cause of the disease with hospitals, NHS centers, 
and the UK government [67]. The Global Initiative on Sharing All Influenza Data is assisting 
rapid sharing of information about the COVID-19 virus with scientists from other regions 
around the world – leading to scientists from the Virus Identification Laboratory based at 
Doherty Institute, Australia, to grow a similar virus after accessing the data shared by Chinese 
scientists [68]. A non-profit collaboration among a score of major biopharmaceutical 
companies will share control arm data from ongoing and planned COVID-19 clinical studies 
and data from past studies in related diseases or patient populations [69]. GSK, AstraZeneca, 
and the University of Cambridge are collaborating in support of the UK’s effort to boost 
COVID-19 testing, with a new laboratory for high-throughput testing and development of 
test alternatives to overcome supply shortages, and with automation and robotics expertise 
for scaling up the production of testing kits [70]. Furthermore, a draft European Parliament 
report on medicine shortages in the face of the pandemic, to be debated in mid-2020, stresses 
“the key contribution that can be made by new technologies and artificial intelligence in 
enabling European laboratory researchers to form networks and share their objectives and 
findings” [71].
11Biomed Hub 2020;5:511232
Horgan et al.: Digitalisation and COVID-19
www.karger.com/bmh
© 2020 The Author(s). Published by S. Karger AG, BaselDOI: 10.1159/000511232
Look What I’ve Found! 
The pandemic has accelerated the shift toward open-access research publication stan-
dards, helping to improve timely access to data in the COVID-19 emergency. Given the many 
unanswered questions on the reservoir, transmission, consequences, and manifestations of 
COVID-19 infection and associated disease, the goal is to encourage all researchers to share 
their data as quickly and widely as possible.
The Bulletin of the WHO will implement a “COVID-19 Open” data sharing and reporting 
protocol, which will assign digital object identifiers to all relevant research manuscripts, and 
post them online within 24 h, while they undergo peer review, making the data available for 
unrestricted use, distribution, and reproduction in any medium [9]. Shifts towards rapid peer 
review and publication online could make valuable contributions on condition that the 
essential scientific rigour is maintained. This could help to meet the urgent need to refine the 
risk assessment with real-time guidance for epidemiologists in containing the outbreak, clini-
cians managing patients, and modellers helping to understand potential future directions and 
the possible effectiveness of various interventions, say leading academics [72]. A registry of 
COVID-19 patients in the USA from collated de-identified health records is being compiled, 
free for government and academic access, to help research into disease spread, vulnerable 
population groups, and treatment effectiveness. Data from medical insurance claims are also 
to be added [73].
The US White House is inviting AI experts and research organisations to make use of the 
COVID-19 Open Research Dataset of 29,000 peer-reviewed research papers on the corona-
virus group to elucidate scientific questions about COVID-19 [74, 75]. Hundreds of stake-
holders from across government, academia, industry, and the general public are backing a call 
for action spearheaded by New York University to develop the potential of data collaboration 
in addressing the pandemic [76] (Fig. 2).
What’s That on the Horizon?
A Perspective on Personalised Medicine!
The COVID-19 lessons and changes could accelerate progress towards the still-distant 

























Fig. 2. RWE (real-world evidence) throughout medicines decision making.
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protective and secure data sharing are pre-conditions, as acknowledged by the International 
Consortium of Personalised Medicine (IC-PerMed), and as is implicit in the signature by 21 
EU member states of the “1+ Million Genomes” Initiative (1+MG), which aims to deliver cross-
border access to existing and future genomic databases, making at least 1 million genomes 
accessible in the EU by 2022 [77].
The dependence of rare diseases on data sharing makes them uniquely positioned to 
drive the technical implementation of an ethically and legally compliant federated network 
of data resources enabling cross-border data access. To incorporate some of the mantras 
heard during the COVID-19 crisis – screening, early detection, testing – into health practices 
for cancer, dementias, or autism is one of the challenges of the new period.
All Hands on Deck
Use My Data, but Carefully!
The public are increasingly aware of the power of individual and population-level data to 
understand the pandemic, and are demonstrating a willingness to share personal data, while 
maintaining data privacy standards. Some 320,000 Israelis have responded to a smartphone-
based questionnaire designed to identify and predict virus hot zones [78]. Hundreds of thou-
sands of Canadians rapidly contributed to a data pool of symptoms (or lack thereof) that 
anonymously generates a heatmap [79]. A culture-related readiness to permit use of personal 
data has been observed in China and across Asia [45]. The pilot of an online tool coupled with 
physical mobile testing sites has won rapid acceptance among high-risk people in the San 
Francisco Bay Area [80]. A platform to gather data from people at home and report it to public 
health organisations has been created by Silicon Valley engineers to foster participatory 
surveillance and combat the lack of testing [81].
Feeding New Public Hunger for Information
The power of personal health data and the growing public engagement with personal 
choices has created new appetites for information about individuals’ data and how they can 
benefit from its exploitation. For this to work to universal benefit, all stakeholders need the 
digital literacy and capacity to contribute, use and benefit from health data responsibly, ethi-
cally, and sustainably. At the same time, effective information provision to the public – about 
the pandemic and about the uses their data can be put to – can also benefit frontline health 
professionals and policy makers, reduce public panic, and help in promptly communicating 
crucial findings to the international scientific community. 
The crisis represents an opportunity to stimulate societal participation through citizens’ 
involvement and broad stakeholder engagement by engaging society in a co-management 
strategy where citizens play a proactive role. This effort will also contribute to building a 
scientifically literate patient community and support their involvement in science and tech-
nological development.
The demand for rapid access to information among both expert and general audiences is 
triggering the use of rapid approaches to knowledge sharing, and the elimination of typical 
barriers/delays, such as paywalls, and reassessment of peer review processes. In recognition 
of this demand, and of the importance of reaching the largest possible audience with public 
health guidance, numerous news agencies – such as New York Times, Washington Post, and 
Globe and Mail – have removed paywalls that would prevent access to reports on the COVID-19 
pandemic.
An analysis in Google Trends demonstrates that the volume of Google searches for “CoV” 
during the past 5 years has increased by many orders of magnitude since the beginning of the 
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2019-nCoV outbreak, especially in China [82]. A diverse global community of academic, 
industry, government, and not-for-profit stakeholders have called for rapid sharing of 
research data relevant to the COVID-19 outbreak [83], which is driving a surge in (unref-
ereed) preprints. To help pinpoint the most important research, the Wellcome Trust has 
supported the launch of an open-source platform for rapid review of preprints related to 
emerging outbreaks [84]. To allow real-time sharing of scientific information, many interna-
tional academic journals have speeded up their review and publication of articles on COVID- 
19, and specific coronavirus websites have been created by publishers such as NEJM and The 
Lancet. Many articles have also been translated between Chinese and English [85].
Social media has given real-time public access to data analysis and commentary from 
experts, including influential exchanges inciting or announcing disclosure and flagging signif-
icant omissions or misattributions [86]. Analysis of internet usage in the USA shows shifts in 
online behaviour, as citizens searching for information on the public health crisis and its 
economic consequences has increased traffic to local news sites and more established media 
brands [87]. Coronavirus dashboard applications have experienced increased demand – in 
the hundreds of millions – demonstrating public eagerness to track health threats [45].
Fighting Fake News
The importance of accuracy and the danger of misinformation are driving new standards 
and policies in health information provision. Although the improvement of internet commu-
nication largely enhances the availability and dissemination of knowledge, the internet also 
has the potential for the development and spread of misinformation or fake news, and there 
is growing pressure on governments and technology companies to take responsibility for 
providing accurate knowledge and clarifying misinformation to help the public in this unprec-
edented situation [88].
Leading social media and tech organisations say they are “working closely together on 
COVID-19 response efforts […] helping millions of people stay connected while also jointly 
combating fraud and misinformation about the virus, elevating authoritative content on our 
platforms, and sharing critical updates in co-ordination with government healthcare agencies” 
[89]. The Canadian government is contemplating introducing legislation to make it an offence 
to knowingly spread misinformation that could harm people, including misinformation online 
about the COVID-19 pandemic [90].
Action Stations!
 • It is now more urgent than ever that health systems across Europe invest substantially 
in improving the quality of the data captured in routine healthcare.
 • Minimum quality standards must be set and adopted for the capability of EHR systems 
to capture and represent high-quality detailed health information and genomic infor-
mation in a well-structured and coded form, adhering to interoperability standards.
 • eHealth services must now scale up the use of telemedicine and telemonitoring, as these 
are known to deliver good health outcomes and to be cost effective, supported by trust-
worthy AI to monitor high-volume data streams for potential health issues needing health 
professional intervention.
 • Individuals must be encouraged to utilise quality labelled and interoperable apps and 
devices to provide their own health and activity data to health systems and public health 
agencies.
 • Plans, policies, and legislation must now be put in place in all countries to rapidly enable 
future citizen data to be collected securely to track and trace infections and infectious 
14Biomed Hub 2020;5:511232
Horgan et al.: Digitalisation and COVID-19
www.karger.com/bmh
© 2020 The Author(s). Published by S. Karger AG, BaselDOI: 10.1159/000511232
contacts, and for this data to be reused anonymously for monitoring and rapid response 
planning.
 • The infrastructure to exchange detailed clinical information security (not just patient 
summaries and lab data) must now be scaled up within and between countries.
 • Research infrastructures must be funded and supported to comply with the GDPR but 
still enable big data analysis to be conducted rapidly and accurately.
 • Countries must put in place organisational structures and policy instruments to continu-
ously undertake effective and prompt international sharing of accurate and complete 
public health intelligence, co-operating openly on challenges as well as progress.
 • Countries and public health agencies must gear themselves to be the primary trustworthy 
provider of information to the public about the status, predictions, and measures being 
taken in response to a future pandemic, as a source of facts that is clearly separated from 
political decision making; this includes rapidly responding to counter fake news.
 • Policy instruments are needed to facilitate greater and just-in-time public, private, and 
inter-company collaboration, including in areas such as data sharing, risk sharing, 
liability, IP, and costs, in response to future public health emergencies.
 • The European Commission, whilst understandably prioritising Europe and its citizens, 
must play a proactive global role in these actions in recognition that European citizens 
are impacted by global health issues.
Land ho!
Health Data Is Becoming More Widely Accepted
Data and digital literacy are emerging as an asset among political leaders and the general 
public, increasingly accepted as assisting sound decision making and knowledge transfer and 
connectivity during times of physical distancing. However, the merits are dependent in large 
measure on the skills of the population – which are not evenly distributed across social groups 
or the demographic. 
In Taiwan, the medical expertise of many political leaders influenced the rapid action to 
counter COVID-19, including the immediate development and deployment of a centralised 
mobile application to disseminate information to citizens, informing them of transmissions, 
areas to avoid, and best health practices. The app was able to effectively track the virus, 
creating a constant and reliable stream of information from the relevant authorities directly 
to the public. As cases appeared, Taiwan had a system for effectively and consistently alerting 
citizens [91]. The focus that the pandemic has put on the benefits of remote care has also high-
lighted the disparate skill levels within populations, leaving some – and particularly the 
elderly – less able to seek or access remote care [92]. It has also exposed the lack of access to 
high-speed internet, and the related problem of a growing digital divide [93–95] (Fig. 3).
The Future Must Be Digital
COVID-19 has highlighted the unarguable reality that population health and economic 
health are intertwined and underlined the need for new ways to measure and share related 
data. The world is confronted with a compelling demonstration of the need to accelerate digi-
talisation of healthcare systems around the world. This is ultimately a political issue, and 
although some jurisdictions have made progress, new policies to enable data collection, 
sharing, and analytics, and support the acceptance and adoption of innovative digital tech-
nologies must be enacted at a faster pace to protect patients, ensure health system sustain-
ability, and achieve better health outcomes.
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And It Will Be
The pandemic has crystallised a vision for – and focus on – the digital data and digital data 
exchange tools that will improve healthcare systems. The need for rapid data exchange and 
effective interoperability as vital public health issues has been repeatedly emphasised by 
senior academics and researchers [17]. It is seen by some as a test-case for the future [17], 
and it has given new currency to calls for the development of AI [46].
Advancing data and analytics capabilities is seen as crucial to meeting the challenges of 
current and future health threats. Disease surveillance and response activities are hampered 
by 20th century technology, with critical health data still managed on paper records, non-
searchable EHRs, or in spreadsheets that require extensive manual data entry and analysis. 
[96].
Progress in digitalisation of healthcare that has improved the capacity to respond to 
COVID-19 will be a platform to transform healthcare delivery and specialty care, as numerous 
senior health experts testify. The pandemic will shift the paradigm of where healthcare 
delivery takes place, rescuing telemedicine from the sidelines and repositioning it as a cost-
controlling, high-convenience system as traditional care settings are overwhelmed by the 
pandemic. The containment-related benefits are also given new value: staying home for a 
video call keeps you out of the transit system, out of the waiting room, and away from patients 
who need critical care [97]. The successful application of digital technology to tackle the 
pandemic will increase public and governmental acceptance of such technologies for other 
areas of healthcare, including chronic disease [98]. Artificial barriers to moving many aspects 
of care online will be weakened or eliminated, in everything from allowing billing for tele-
medicine to permitting the use of a wider range of communication tools – including social 

























































Single view of the patient
IT optimisation
Fig. 3. Realising sustainable healthcare means orientating people, processes, and technologies around the 
patient for better outcomes.
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The role of video consultations will be indispensable afterwards, and all healthcare will 
need to be reassessed in light of COVID-19 [99]. Telemedicine will be seen as just another 
component of the care model, in a new post-COVID normal [100].
Digitalisation of health is not just one shipload of advanced technology. It is a flotilla of 
many vessels, armed with many specialisations, techniques, and procedures that can play a 
part in the battle against coronavirus. As this account suggests, some of them have already 
entered the fray, and others are on the point of doing so. Some are still held back, by delays 
in provisioning or the delivery of vital equipment – or, less forgivably, by undue caution and 
even resistance among still-influential stakeholders who do not perceive the merits of digi-
talisation. But as the long campaign against coronavirus evolves, the benefits of digitalised 
healthcare will become steadily clearer, and the eventual victory over COVID-19 will also 
mark a new phase in healthcare systems, in which digitalisation will have securely estab-
lished its place (Fig. 4). 
Conclusion: Digitalisation and Public Health
Digital technologies and the digital environment offer new opportunities for identifying 
needs and delivering healthcare from prevention and health promotion to curative interven-
tions and self-management [101]. As such, they have the potential to transform healthcare 
services in ways that may contribute to health system goals of quality, accessibility, efficiency, 
and equity of healthcare. In this sense, digitalisation should be considered as a means, a set 
of tools, not an aim for public health [102]. A key challenge is to ensure that all people enjoy 
the benefits of digital technologies for everyone. We must make sure as public health profes-
sionals that innovation and technology help to reduce the inequities in our world, instead of 
becoming another reason people are left behind. 
When it comes to the COVID-9 pandemic, we have learnt that mobile apps have the 
potential to bolster contact tracing strategies to contain and reverse the spread of COVID-19. 
In a number of countries worldwide, the use of apps has supported health authorities in moni-
toring and mitigating the ongoing COVID-19 pandemic, facilitated the organisation of medical 
follow-up of patients, and provided direct guidance to citizens on playing their part in the 
control of the disease [103]. The added value of these apps is that they can record contacts 
that a person may not notice or remember. 
The aim of contact tracing and warning is for public health authorities to rapidly identify 
as many contacts as possible with a confirmed case of COVID-19, ask them to self-quarantine 
if possible, and rapidly test and isolate them if they develop symptoms. Contact tracing is 
normally carried out manually by public health authorities. This is a time-consuming process 
where cases are interviewed in order to determine who they remember being in contact with 
from 48 h before symptom onset and up to the point of self-isolation and diagnosis.
Liberate the data























Fig. 4. Concerted action is re-
quired across three foundational 
sets of policy actions.
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Digital tools such as mobile apps with tracing functionalities can be of substantial support 
in this process, identifying both known and unknown contacts of a confirmed case and 
possibly help in their follow up, in particular in settings with large numbers of cases where 
public health authorities can become overwhelmed.
Several member states in the EU and EEA have launched or intend to launch initiatives 
that involve contact tracing apps in the fight against COVID-19. The use of these technologies 
has raised policy questions about privacy and data management, determining different 
approaches in different countries, especially between Asia and Europe. The adoption of the 
digital tools (encouraged or mandatory), a digital infrastructure enabled and activated by the 
national government, and the possibility to share data represent the main conditions and the 
most dilemmas related to the improvement of digital contact tracing strategies. In this sense, 
EU member states should urgently converge towards effective app solutions that minimise 
the processing of personal data, and recognise that interoperability between these apps can 
support public health authorities, especially after the reopening of the EU’s internal borders 
(Fig. 5). 
Outside of Europe, China, South Korea, Taiwan, and Singapore have developed several 
technologies to collect data in order to contain the dissemination of the virus. China adopted 
a government-mandated QR code that shows the level of risk of the citizen in order to recognise 
positive cases. Singapore encouraged people to install an app called “TraceTogether,” which 
uses Bluetooth signals between nearby devices. Similarly, Hong Kong requires all new arrivals 
to download the “StayhomeSafe” app, while in South Korea the “Corona 100 m” app registers 
all personal data and movements by GPS that can be used by the government. Taiwan used a 
similar approach, where the contact tracing system allows the government to contact citizens 
to ensure they do not evade tracking by leaving their devices at home. 
Apps developed in Europe, instead, are based on voluntary use, without a government 
obligation. For example, from June 2020, Italy developed the app “Immuni” that is recom-
mended, but not mandatory. This app uses a Bluetooth signal that allows recognising possible 
exposition to positive cases. The French app “StopCovid” works similarly and it is based on 
voluntary use, as is the German app “Corona-Warn-App.”
There is evidently a different approach in digital contact tracing between Europe and 
Asia. This could be related to differences at political level but also to the characteristics of the 
population, where the collectivist spirit of Asian Countries may encourage a common action 



























Fig. 5. Key participants in the 
healthcare open innovation eco-
system.
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can only help control the UK COVID-19 epidemic if they are effectively implemented and form 
part of a wider package of interventions that include social distancing, infection control, and 
hygiene measures [104].
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